4//SEC Filing
HUMPHREY RACHEL 4
Accession 0001140361-17-046649
CIK 0001501989other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 12:23 PM ET
Size
6.9 KB
Accession
0001140361-17-046649
Insider Transaction Report
Form 4
HUMPHREY RACHEL
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2017-12-15$6.61/sh+15,117$99,994→ 30,234 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-12-15−15,117→ 262,980 totalExercise: $6.61Exp: 2025-08-27→ Common Stock (15,117 underlying)
Footnotes (1)
- [F1]This option vests 25% on August 28, 2016, and the remaining 75% vests in 36 substantially equal monthly installments thereafter, with each additional installment vesting on the last day of the month, except the final installment, which shall vest on August 28, 2019.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001579781
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 12:23 PM ET
- Size
- 6.9 KB